New Applications Data Demonstrates High Quality Peptide Synthesis
News Nov 26, 2008
Activotec has announced the availability of new applications data that demonstrates why the Activo-P11 Peptide Synthesizer is the peptide synthesizer of choice for a growing number of laboratories worldwide.
The Activo-P11 Peptide Synthesizer is an instrument for synthesis of very high quality peptides. The Activo-P11 offers the versatility to synthesize peptides of any length in the 0.1 - 2 mmoles scale in t-Boc or Fmoc chemistry, using any kind of activation.
Chris Littlewood, Chief Executive of Activotec, commented "Since its launch in 2007 - market reaction to the Activo-P11 has been extremely positive, installations in peptide laboratories worldwide have exceeded even our most optimistic expectations".
He added "We are the only European company with international service and support teams that are exclusively focused on peptide synthesis instrumentation and services. This enables Activotec to be uniquely positioned to provide customers with informed technical assistance enabling them to get the most from their peptide synthesizer".
Staphylococcus epidermidis is an ubiquitous colonizer of healthy human skin, but it is also a notorious source of serious nosocomial infections. Now, a new machine learning technique will help predict the risk of developing a serious, and possibly life-threatening S. epidermidis infection.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
10th International Tissue Repair and Regeneration Congress
Jun 13 - Jun 14, 2019